基本資料
種類: ETF
費用比率%: --
資產淨值: 27.99
成立日期: //
 
分析
市值分佈:
58.28%
大市值
13.60%
中市值
2.61%
小市值
持股比例加總可能不達100%,原因包括ETF持有現金或衍生工具。
 
 
行業分佈 國家/地區分佈
 
投資組合
 (更新時間: 14/11/2026 05:09) 總持有投資項目: 27  
0%
 
100%
     10大 (58.32%)
代號 名稱 佔比% ▼ 持有日期
LLYEli Lilly & Co13.8930/10/2026
NVONovo-Nordisk A/S10.0230/10/2026
PODDInsulet Corp8.1130/10/2026
PTGXProtagonist Therapeutics6.9830/10/2026
RYTMRhythm Pharmaceuticals4.8130/10/2026
VKTXViking Therapeutics3.7930/10/2026
IPSEFIpsen S.A.2.9230/10/2026
PBLSParabilis Medicines Inc2.7030/10/2026
ZLDPFZealand Pharma A/S2.6930/10/2026
AUPHAurinia Pharmaceuticals2.4030/10/2026
MBXMBX Biosciences Inc.2.1030/10/2026
NURPFNeuren Pharmaceuticals Ltd.1.9030/10/2026
ACADACADIA Pharmaceuticals1.7030/10/2026
TNDMTandem Diabetes Care1.6030/10/2026
AMLXAmylyx Pharmaceuticals1.4830/10/2026
CAMRFCamurus AB1.2930/10/2026
XERSXeris Biopharma Holdings0.9030/10/2026
KLRAKailera Therapeutics Inc0.9030/10/2026
PPTDFPeptidream, Inc.0.8230/10/2026
PLYGFPOLYPEPTIDE GROUP AG0.7030/10/2026
 1    2  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.